Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON42086Active, not recruiting
Randomised, open-label trial of diclofenac and Dimethyl sulfoxide in inflammatory diseases (3 arms), sponsored by PRA Health Sciences. Primary endpoint: Single-dose and multiple-dose pharmacokinetics of diclofenac and dimethyl sulfoxide. Started Nov 2014; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON42086.